Cargando…

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia

Acute myeloid leukemia (AML) accounts for approximately 15–20% of all childhood leukemia cases. The overall survival of children with acute myeloid leukemia does not exceed 82%, and the 5-year event-free survival rates range from 46% to 69%. Such suboptimal outcomes are the result of numerous mutati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obszański, Piotr, Kozłowska, Anna, Wańcowiat, Jakub, Twardowska, Julia, Lejman, Monika, Zawitkowska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230975/ https://www.ncbi.nlm.nih.gov/pubmed/35745032 http://dx.doi.org/10.3390/molecules27123911

Ejemplares similares

CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma
por: Ostojska, Magdalena, et al.
Publicado: (2023)

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021)

CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
por: Zarychta, Julia, et al.
Publicado: (2023)

Severe complications in the induction phase of therapy in a pediatric patient with T-cell acute lymphoblastic leukemia: A case report
por: Rocka, Agata, et al.
Publicado: (2023)

Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report
por: Stefaniak, Martyna, et al.
Publicado: (2021)

Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
por: Górecki, Mateusz, et al.
Publicado: (2023)

The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lato, Marta Weronika, et al.
Publicado: (2021)

Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
por: Kośmider, Kamil, et al.
Publicado: (2022)

Editorial: Diagnosis and therapy pediatric hematological malignancies: recent progress
por: Zawitkowska, Joanna, et al.
Publicado: (2023)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Electrochemical and Optical Sensors for the Detection of Chemical Carcinogens Causing Leukemia
por: Kowalczyk, Adrian, et al.
Publicado: (2023)

Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lejman, Monika, et al.
Publicado: (2020)

Diagnostic difficulties of AH1N1 influenza infection in children with acute lymphoblastic leukemia: Two case reports
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
por: Malczewska, Marta, et al.
Publicado: (2022)

Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia
por: Panuciak, Kinga, et al.
Publicado: (2023)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
por: Derebas, Justyna, et al.
Publicado: (2022)

Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia
por: Mroczek, Anna, et al.
Publicado: (2021)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia
por: Drożak, Paulina, et al.
Publicado: (2022)

Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias
por: Panuciak, Kinga, et al.
Publicado: (2022)

Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
por: Xu, Huan, et al.
Publicado: (2022)

The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL
por: Lejman, Monika, et al.
Publicado: (2020)

Molecular landscape and targeted therapy of acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2018)

The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
por: Leśniak, Maria, et al.
Publicado: (2023)

Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Jędraszek, Krzysztof, et al.
Publicado: (2022)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
por: Chen, Jing, et al.
Publicado: (2020)

Molecular targeting in acute myeloid leukemia
por: Lim, Seah H., et al.
Publicado: (2017)

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
por: Ahmadmehrabi, Khashayar, et al.
Publicado: (2021)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies—A Review
por: Filipiuk, Aleksandra, et al.
Publicado: (2022)

The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia
por: Ziętara, Karolina Joanna, et al.
Publicado: (2023)

Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia
por: Tomizawa, Daisuke, et al.
Publicado: (2023)

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
por: Arai, Hironori, et al.
Publicado: (2022)

Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation
por: Lejman, Monika, et al.
Publicado: (2019)

Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Resistance to targeted therapies in acute myeloid leukemia
por: Mecklenbrauck, Rabea, et al.
Publicado: (2022)

Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g0iggd2nq87pj78ldunlmikf0v